← Back to Search

ATTACH™ Parenting Program for Parent-Child Relationship (ATTACH™ Trial)

N/A
Recruiting
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline pcits scores after completion of intervention and at 3 months.
Awards & highlights

ATTACH™ Trial Summary

This trial sought to test the efficacy of the ATTACH parenting intervention in reducing stress-related health problems in children. The study found that ATTACH was successful in reducing stress and improving health outcomes for children. However, the study was limited by its small sample size and lack of long-term data.

Who is the study for?
The ATTACH™ Program is for parents with children from birth to 32 months who are dealing with toxic stress factors like depression, addictions, or poverty. Parents must commit to weekly training sessions for 10-12 weeks and agree to bring a co-parent when possible. They also need to consent to blood sample collection in certain locations.Check my eligibility
What is being tested?
This trial tests the ATTACH™ Parenting Program's effectiveness when delivered by healthcare professionals in community settings. It aims at improving parent-child relationships and child development outcomes by enhancing parents' understanding of thoughts and feelings (reflective function).See study design
What are the potential side effects?
Since ATTACH™ is an educational program rather than a medical treatment, it doesn't have side effects like drugs do. However, participants may experience emotional discomfort or distress while reflecting on personal experiences during the program.

ATTACH™ Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline prfq scores after completion of intervention and at 3 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline prfq scores after completion of intervention and at 3 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Parent-Child Relationship Quality will be measured by Parent Child Interaction Teaching Scale (PCITS).
Secondary outcome measures
Child Development, measured by Ages and Stages Questionnaire - 3rd Edition
Parental Reflective Function will be measured by Parental Reflective Function Questionnaire (PRFQ).

ATTACH™ Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention groupExperimental Treatment1 Intervention
A quasi-experimental design was selected to more closely approximate service delivery models in agencies that do not typically employ control groups. Given promising findings (from seven ATTACH™ pilot studies), a randomized controlled trial design, even employing wait-list controls was deemed unacceptable and even unethical by patients, health care professionals and health system administrators in engagement activities surrounding the preparation of this proposal.

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
792 Previous Clinical Trials
868,854 Total Patients Enrolled

Media Library

ATTACH™ Parenting Program Clinical Trial Eligibility Overview. Trial Name: NCT04853888 — N/A
Parent-Child Relationship Research Study Groups: Intervention group
Parent-Child Relationship Clinical Trial 2023: ATTACH™ Parenting Program Highlights & Side Effects. Trial Name: NCT04853888 — N/A
ATTACH™ Parenting Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04853888 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are being administered this experiment?

"Affirmative. According to the clinical trial information hosted on clinicaltrials.gov, recruitment for this study is currently underway. It was posted on September 1st 2021 and last modified July 11th 2022; 300 participants are needed from one site location."

Answered by AI

Are there vacancies in this clinical investigation for participants?

"Affirmative. Evident on clinicaltrials.gov, this medical study is presently gathering patients - the initial announcement was made on September 1st 2021 and it has since been revised on July 11th 2022. 300 people must be recruited from a single research facility."

Answered by AI
~34 spots leftby Aug 2024